News
CSSPF
0.650
NaN%
--
NIOX Launches 2026 Employee Share Save Scheme With Discounted Options
TipRanks · 05/05 15:29
NIOX Group Sets Timetable for 2025 Final Dividend
TipRanks · 04/24 16:22
NIOX CEO Reshapes Shareholdings With ISA Transfers
TipRanks · 04/21 11:28
NIOX Group Sets Date and Details for 2026 Annual General Meeting
TipRanks · 04/21 09:28
NIOX Directors Exercise Options as Share Capital Rises
TipRanks · 04/17 17:02
NIOX Group aligns executive incentives with growth via new performance share options
TipRanks · 04/09 13:11
NIOX streamlines share schemes with block listing update and cancellations
TipRanks · 04/02 16:14
NIOX issues new shares to CEO under deferred bonus plan, updates voting rights
TipRanks · 04/01 06:26
NIOX Group boosts revenue, cash and dividend on growing global demand for FeNO diagnostics
TipRanks · 03/24 07:21
NIOX Seeks Block Admission for 4.9 Million New AIM Shares
TipRanks · 03/16 16:32
NIOX Group Updates Total Voting Rights After Employee Option Exercises
TipRanks · 02/27 10:12
NIOX Group Updates Total Voting Rights Following Employee Option Exercises
TipRanks · 01/30 10:07
Niox Group price target lowered to 86 GBp from 90 GBp at Deutsche Bank
TipRanks · 01/21 17:40
NIOX lifts revenue 17% and beats profit forecasts as new NIOX PRO device debuts
TipRanks · 01/20 07:15
NIOX Group Corrects Advisory Error and Seeks Block Admission of New Shares for SAYE Scheme
TipRanks · 01/16 08:22
NIOX Seeks AIM Admission for New Shares Under 2023 Employee Option Plan
TipRanks · 01/16 07:08
NIOX Updates Total Voting Rights Following Employee Option Exercises
TipRanks · 12/31/2025 09:52
NIOX CFO Increases Stake with Share Purchase
TipRanks · 12/04/2025 07:11
NIOX Group Announces Block Listing Application for New Shares
TipRanks · 11/26/2025 11:57
NIOX Group Updates Total Voting Rights Following Share Option Exercises
TipRanks · 10/31/2025 14:27
More
Webull provides a variety of real-time CSSPF stock news. You can receive the latest news about Niox Group Plc through multiple platforms. This information may help you make smarter investment decisions.
About CSSPF
NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.